Study of large intestine in retention of faeces in relation with fecal calprotecti
Phase 2
Not yet recruiting
- Conditions
- Health Condition 1: K638- Other specified diseases of intestine
- Registration Number
- CTRI/2022/12/048079
- Lead Sponsor
- Dr Sachin Rangrao Patil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Selected 120 diagnosed patients of purishaja udavarta
Exclusion Criteria
Patients below 40 years and above 60 yearsAvirecya
Patients taken non-steroidal anti-inflammatory drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of pakvashaya is possible on the basis of investigation range of fecal calprotectinTimepoint: 3 weeks
- Secondary Outcome Measures
Name Time Method 1.Relieving of Mala sang and reduction in sign and symptoms of purishaja udavarta vyadhi <br/ ><br>2.Effect of Eranda taila on gut biomarkersTimepoint: 3 weeks